115 related articles for article (PubMed ID: 6851447)
1. [Effect of lisuride in the "on-off" phenomena due to L-dopa].
Piccinin GL; Piccirilli M; Rizzo PA; Agostini L
Clin Ter; 1983 Mar; 104(6):469-71. PubMed ID: 6851447
[No Abstract] [Full Text] [Related]
2. Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
Ruggieri S; Stocchi F; Carta A; Bravi D; Bragoni M; Giorgi L; Agnoli A
Mov Disord; 1988; 3(4):313-9. PubMed ID: 3211176
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine and lisuride in Parkinson's disease.
Caraceni T; Giovannini P; Parati E; Scigliano G; Grassi MP; Carella F
Adv Neurol; 1984; 40():531-5. PubMed ID: 6695632
[No Abstract] [Full Text] [Related]
4. Lisuride infusion pump for Parkinson's disease.
Lancet; 1986 Aug; 2(8502):348-9. PubMed ID: 2874360
[No Abstract] [Full Text] [Related]
5. [Oral lisuride in Parkinson's disease].
Obeso JA; Luquin MR; Martínez Lage JM
Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822
[No Abstract] [Full Text] [Related]
6. Lisuride combined with levodopa in advanced Parkinson disease.
Lieberman AN; Goldstein M; Leibowitz M; Neophytides A; Gopinathan G; Walker R; Pact V
Neurology; 1981 Nov; 31(11):1466-9. PubMed ID: 7031504
[TBL] [Abstract][Full Text] [Related]
7. Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease. The French Lisuride Study Group.
Allain H; Destée A; Petit H; Patay M; Schück S; Bentué-Ferrer D; Le Cavorzin P
Eur Neurol; 2000; 44(1):22-30. PubMed ID: 10894991
[TBL] [Abstract][Full Text] [Related]
8. Pergolide and lisuride for Parkinson's disease.
Lieberman AN; Leibowitz M; Neophytides A; Kupersmith M; Mehl S; Kleinberg D; Serby M; Goldstein M
Lancet; 1979 Nov; 2(8152):1129-30. PubMed ID: 91856
[No Abstract] [Full Text] [Related]
9. [Parkinson disease--problems in long-term treatment. Dopamine agonists optimize L-dopa therapy].
Fuchs G
Fortschr Med; 1997 Feb; 115(5):43-5. PubMed ID: 9162718
[TBL] [Abstract][Full Text] [Related]
10. [Continuous dopaminergic stimulation in Parkinson disease].
Obeso JA; Luquin MR; Vaamonde J; Grandas F; Pastor MA; Artieda J; Martínez-Lage JM
Neurologia; 1987; 2(5):227-34. PubMed ID: 2908545
[No Abstract] [Full Text] [Related]
11. Chronic s.c. lisuride in Parkinson's disease--motor-performance and avoidance of psychiatric side effects.
Bittkau S; Przuntek H
J Neural Transm Suppl; 1988; 27():35-54. PubMed ID: 3165438
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine and lisuride in Parkinson disease.
Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
[TBL] [Abstract][Full Text] [Related]
13. [Orally administered lisuride in the treatment of complex fluctuations of motion in Parkinson disease].
Luquín MR; Obeso JA; Vaamonde J; Martínez Lage JM
Neurologia; 1989 Sep; 4(7):229-32. PubMed ID: 2638588
[TBL] [Abstract][Full Text] [Related]
14. A study on the effect and tolerance of lisuride on Parkinson's disease.
Bayülkem K; Erişir K; Tuncel A; Bayülkem B
Adv Neurol; 1996; 69():519-30. PubMed ID: 8615174
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic results with a new ergoline derivate (8-alpha-amino-ergoline, CU 32-085) in parkinsonian patients.
Schneider E; Hubener K; Fischer PA
Adv Neurol; 1984; 40():527-9. PubMed ID: 6695631
[No Abstract] [Full Text] [Related]
16. [On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation].
Stocchi F; Ruggieri S; Baronti F; Bellantuono P; Brughita G; Antonini A; Bravi D; Agnoli A
Clin Ter; 1987 Jul; 122(2):83-8. PubMed ID: 2973904
[No Abstract] [Full Text] [Related]
17. Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
Stocchi F; Ruggieri S; Brughitta G; Agnoli A
J Neural Transm Suppl; 1986; 22():209-18. PubMed ID: 3465872
[TBL] [Abstract][Full Text] [Related]
18. Continuous dopaminergic stimulation in the management of complicated Parkinson's disease.
Agnoli A; Stocchi F; Carta A; Antonini A; Bragoni M; Ruggieri SA
Mt Sinai J Med; 1988 Jan; 55(1):62-6. PubMed ID: 3258057
[No Abstract] [Full Text] [Related]
19. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
Pahwa R; Koller WC
Adv Neurol; 1996; 69():487-91. PubMed ID: 8615169
[No Abstract] [Full Text] [Related]
20. [Lisuride in Parkinson disease].
Leiguarda R; Micheli F; Fernández Pardal M
Medicina (B Aires); 1985; 45(1):29-34. PubMed ID: 3880105
[No Abstract] [Full Text] [Related]
[Next] [New Search]
